1.
Fasano M, Colombo GL, Di Matteo S, et al. Cost-effectiveness of tenofovir in the treatment of patients with chronic hepatitis B: data from literature. Farmeconomia. Health Economics and Therapeutic Pathways. 2014;15(1):15-26. https://doi.org/10.7175/fe.v15i1.908